跳至主要内容
临床试验/NL-OMON43380
NL-OMON43380招募中不适用

The long-term follow-up interferon-a treatment for chronic hepatitis B infection - ELITE-B study

Stichting Leveronderzoek0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Chronic hepatitis B infection, defined as HBsAg positivity >=6 months
  • - Interferon-a (conventional, or peginterferon-a) treatment between 1978 and 2014

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study for analysis of the endpoints of morbidity and mortality only:
  • - patients who have been diagnosed with hepatitis C (HCV), hepatitis delta (HDV) or human immunodeficiency virus (HIV) coinfection , as coinfections are associated with more severe liver disease

研究者

发起方
Stichting Leveronderzoek

相似试验